Avilex Pharma ApS

https://www.avilexpharma.com

Avilex Pharma is a Danish biotech company with technology developed at the Department of Drug Design and Pharmacology of the University of Copenhagen. Through the use of innovative dimeric ligands we can target well established intracellular targets with unprecedented potency with the aim of developing novel medicines for a range of areas of unmet medical need. *

	Start	2013-04-15 splitoff (date ca.)
	Predecessor	University of Copenhagen
	Industry	drug development
	Person	Tansley, Robert (Cambridge Innovation Capital 201401– Investment Director before KalVista + Avilex Pharma)
	Person 2	Strømgaard, Kristian (Univ Copenhagen 201304 Prof Avilex Pharma ApS –201304– CSO + Co-founder)

	Region	København (Copenhagen)
	Country	Denmark
	Street	3 Ole Maaløes Vej
	City	2200 København
	Tel	+45-3527-6599
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2024-02-12

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)